Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome

Leuk Lymphoma. 2022 Oct;63(10):2499-2502. doi: 10.1080/10428194.2022.2074992. Epub 2022 May 13.

Authors

Affiliations

¹ Department of Hematology/Oncology, Wakayama Medical University, Wakayama, Japan.
² Department of Internal Medicine, Kainan Municipal Medical Center, Wakayama, Japan.
³ Department of Human Pathology, Wakayama Medical University, Wakayama, Japan.

PMID: 35561254
DOI: 10.1080/10428194.2022.2074992

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Castleman Disease* / diagnosis
Castleman Disease* / drug therapy
Humans
Plasma Exchange*
Receptors, Fc
Recombinant Fusion Proteins
Rituximab / therapeutic use
Steroids
Thrombopoietin

Substances

Receptors, Fc
Recombinant Fusion Proteins
Steroids
Rituximab
Thrombopoietin
romiplostim

Supplementary concepts

Multi-centric Castleman's Disease